Epizyme, Inc.
Clinical trials sponsored by Epizyme, Inc., explained in plain language.
-
New hope for lymphoma patients: study tests targeted pill for Tough-to-Treat cancers
Disease control TerminatedThis study looked at how well and how safely the drug tazemetostat works in adults with a type of blood cancer called follicular lymphoma that has come back or not responded to previous treatments. Participants took tazemetostat pills twice daily. The study aimed to see if the dr…
Phase: PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated May 17, 2026 02:45 UTC
-
New hope for hard-to-treat lymphoma: drug combo aims to keep cancer at bay
Disease control OngoingThis study is for people with follicular lymphoma, a type of blood cancer, that has returned or no longer responds to treatment. It tests whether adding the drug tazemetostat to a standard two-drug combination can help patients live longer without their cancer getting worse. Abou…
Phase: PHASE3 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated May 17, 2026 02:43 UTC